- Republicans Fret Over RFK Jr.’s Anti-Vaccine Policies While MAHA Moms Stew
- As Lung Disease Threatens Workers, Lawmakers Seek Protections for Countertop Manufacturers
- 5 state behavioral health policy updates
- Oregon’s anti-consolidation bill tested by physician contract switch-up
- Mass General Brigham, Dana-Farber to coordinate on split: Boston Globe
- How AI-enabled early detection is redefining preventive care
- Medical device maker Stryker hit with cyberattack
- New York university to launch dental school
- Aetna to pay $118M to resolve Medicare Advantage upcoding allegations
- Fraud lawsuits against Erlanger can proceed, judge rules
- Medical debt linked to deferred dental care: Study
- FDA launches single adverse event platform
- Riverside Health taps new system finance leader, hospital president
- Medicare beneficiaries may pay more amid insurer acquisitions of PBMs: Study
- Medicare beneficiaries may pay more amid insurer acquisitions of PBMs: Study
- Virginia Mason Franciscan exec heads to Providence
- IU Health bets on ‘big, one-time endeavors’ for the future
- IU Health bets on ‘big, one-time endeavors’ for the future
- Atrium Health Wake Forest Baptist taps hospital president
- ADHA targets professional autonomy in new strategic plan: 5 notes
- Duke University Health System files CON for $6.4M ASC
- Ohio dental practice to permanently close
- 3 health systems outsourcing RCM functions
- A flurry of noncompete updates in Q1
- Specialty1 Partners continues 2026 growth with new joint venture
- The CMS loophole shrinking ASC access: Inside ASCA advocacy
- CMS imposes equipment supplier moratorium; 3 sentenced to prison in fraud cases
- Guidelight names chief growth officer
- ‘A delta in opportunity’: The savings independent ASCs are leaving on the table
- Despite insurers' expense pains, Tenet Healthcare is securing healthy commercial rates through 2027
- Nebraska Medicine’s $99.3M center to expand behavioral health services
- FDA approves 1st treatment for cerebral folate deficiency tied to autistic features
- 8 health system rating downgrades
- The looming impact of site-neutral payments on ASCs
- Dental industry headed for consolidation shift amid DSO financial woes: 4 notes
- Why this anesthesia leader says stipends are here to stay
- Northwestern Medicine opens expanded outpatient center
- Meet the ASC industry’s ‘alternative to the traditional MSO’
- University of Minnesota dental clinic closes over financial challenges
- Study Links State Taxes to COVID Lockdown Decisions
- Hospital expenses grew twice as fast as prices in 2025: 4 AHA findings
- Aetna to pay $117.7M to settle Medicare Advantage upcoding allegations: DOJ
- Connecticut fines debt collector $100K for calls to hospital emergency line
- ADA names Dr. Nader Nadershahi as executive director
- Connecticut health system strikes RCM partnership
- Stryker hit by international cyberattack linked to pro-Iran group
- AHA: Hospitals' total expenses rose by 7.5% in 2025
- AstraZeneca recruits Joshua Jackson, Philadelphia Flyers’ Gritty to cancer screening push
- As Lilly flourishes in Q4, peer projections signal looming sector slowdown in 2026
- FDA May Allow Some Flavored Vapes Aimed at Adults
- Dark Sweet Cherries May Help Slow Aggressive Breast Cancer, Mouse Study Suggests
- FDA Approves Leucovorin for Rare Brain Disorder, Not Autism
- Joint Economic Committee report: Medicare Advantage overpayments drive up Part B premiums
- Veeva shells out $100M for Ostro and its AI chat tool for pharma brand engagement
- Lilly beefs up oral GLP-1 capacity with $3B manufacturing pledge in China
- UCB's Bimzelx continues winning streak with victory over AbbVie's Skyrizi
- Lowering Parents' Stress Can Reduce Risk Of Childhood Obesity
- Multilingualism Might Not Aid Brain Aging, Researcher Argues
- 15-Year Study Shows Sharp Rise in Depression Among U.S. College Students
- Repealing Motorcycle Helmet Laws Leads to More Severe Crashes, Millions in Added Treatment Costs
- Why Childhood Cavities May Predict Adult Heart Disease
- Physical Therapy Costs Vary Widely In U.S., Study Finds
- J&J's Joaquin Duato joins $30M CEO pay club with 30% compensation boost for 2025
- Primary Care Is in Trouble. So Doctors Band Together To Boost Their Market Power.
- Cosmetic Surgery Investigation Prompts Warnings for Patients, and a Push for Tighter Safety Standards
- Skyhawk taps Teva alum to steer commercial path, while Santhera names new CCO to grow DMD sales
- Driving the news at HIMSS26: Verily, Samsung ink collaboration; Meditech's latest AI solutions
- Minnesota to give $5M in restitution to patients of shuttered dental office
- Colorado hospitals, advocates launch youth mental health coalition
- Pennsylvania hospital CFO on life after bankruptcy: ‘You’ve got to hold the line’
- Medicare allegedly paid $15M+ for ED services tied to non-ED sites: Report
- Climate warming could increase anxiety, depression: Study
- Sutter Health boosts operating margin to 2.6% in 2025
- Remarks at the Institute of International Bankers 2026 Annual Washington Conference
- Fostering Regulatory Harmony Between the SEC and CFTC
- Only 4 states satisfy over 50% of mental health workforce needs: Report
- Here's where hospital markets are the most concentrated
- A look at how CVS is leaning on 'agentic twins' in developing consumer tech
- Bancos, primera línea de batalla contra los fraudes financieros a adultos mayores
- Inside Grand Mental Health’s tech-enabled crisis response model
- Sandoz to set up standalone biosimilars unit as it eyes upcoming 'golden decade' of patent losses
- Indiana syringe services face ID requirement, restrictions
- AbbVie's Robert Michael earns hefty pay bump to $32.5M in 2nd year as CEO
- NYU Stern report calls for private equity reforms to safeguard quality of care
- Remarks at the International Bar Association’s 24th Annual International Conference on Private Investment Funds
- Raw Oysters and Clams Recalled After Norovirus-Like Illness Outbreak in Washington
- Mammograms May Also Reveal Hidden Heart Disease Risk, Study Finds
- Chile Becomes First Country in the Americas To Eliminate Leprosy
- Going Abroad? CDC Warns Travelers About Polio Risk in Several Countries
- Listen to the Latest ‘KFF Health News Minute’
- The Fierce Healthcare team on the Fierce 15 of 2026
- Más niños llegan a salas de emergencias con dolor de muelas. Los recortes de Trump y la lucha anti flúor de RFK Jr. no ayudan
- Centene's stock falls as CEO London outlines ongoing ACA headwinds
- AI-fueled misdiagnoses, rural care barriers are 2026's top patient safety threats: ECRI
- Patients want price transparency, e-commerce experience from pharma DTP platforms: survey
- Carrum Health teams up with Virta Health on a comprehensive weight loss solution
- Leerink questions whether BioNTech can thrive without their 'founders' insight' as stock drops
- Novo Nordisk's US headquarters under fire in latest FDA warning letter
- Filana leaves Cassava roots behind amid branch into epilepsy
- Nearly Half of U.S. Kids Lack Adequate Sleep, Survey Shows
- Trump Caused Immediate Decrease in Acetaminophen Rx's For Pregnant Women, Study Finds
- Students Spend A Third Of Their School Day On Their Smartphone, Study Says
- Daily Multivitamins Slow Aging, Clinical Trial Finds
- Stress of Pregnancy Complications Might Impact Future Heart Health, Study Says
- Approved IV Drug, Gazvya, Reduces Lupus Symptoms, Clinical Trial Finds
- CSL telegraphs 300 new hires as it breaks ground on $1.5B plasma-based medicine plant near Chicago
- More Kids Are in ERs for Tooth Pain. Trump Cuts and RFK Jr.’s Anti-Fluoride Fight Aren’t Helping.
- Banks Are Becoming Bulwarks Against Scams for Vulnerable Seniors
- FDA approves leucovorin for ultrarare cerebral folate deficiency subset without clinical trial
- BioNTech's CEO, CMO prep departure to set up next-gen mRNA company
- 12 new behavioral health sites to know
- HIMSS26: Samsung, b.well partner to 'kill the clipboard,' aligning with a key CMS goal
- HIMSS26: Epic expands AI roadmap, previews Factory to build and orchestrate AI agents
- A $21M farewell: Emma Walmsley lands nearly 50% pay hike in final year as GSK chief
- Remarks at the 45th Annual Small Business Forum
- Founders, Funders, and Forty-Five Forums: Remarks at the 45th Annual Small Business Forum
- Remarks at the 45th Annual Small Business Forum
- Leapfrog ordered to remove safety grade for 5 Tenet hospitals
- FDA unveils 4th revision of draft guidance for looser biosimilar testing requirements
- 'Fibermaxxing' Trend Encourages People To Eat More Fiber
- Lilly rewards CEO David Ricks with $36.7M pay package for 2025, fueled by GLP-1 success
- That Stressful Person in Your Life Might Be Aging You Faster, Study Finds
- Newsom se enfrenta a Trump y RFK Jr. por la salud pública
- Infant Bath Seats Sold on Amazon Recalled Due To Tipping Hazard
- FDA Vaccine Chief Dr. Vinay Prasad Exiting Role
- Spruce hooks a commercial chief to prep for rare disease launch
- Hims & Hers makes deal with Novo Nordisk as it shifts obesity strategy
- Fierce Healthcare highlights Fierce 15 of 2026 honorees at NYSE
- Universal Health Services to acquire Talkspace in $835M deal to build out virtual behavioral health
- Novo and Hims make nice, striking deal to sell Ozempic, Wegovy on Hims' telehealth platform
- Sotyktu, take 2: BMS' first-in-class pill gains FDA nod to treat psoriatic arthritis
- 'SNL' pokes fun at mysteries of Amgen's Otezla for plaque psoriasis
- Weighted Vests Help Keep Bones Strong — But Only If Seniors Stay Active
- Small Drop In Measles Vaccinations Tied to Big Jump In Cases
- UV Air Filters Cut Airborne Asthma Triggers, Study Finds
- Many Seniors Gain Physical, Mental Fitness As They Age, Study Finds
- Common Drug Class, Anticholinergics, Shows Links to Heart Risk — Are You Taking One?
- Illicit Drugs Raise Stroke Risk, Even for Younger Adults
- Omada Health swings to a profit in Q4, offers new GLP-1 cash-pay option for employers
- Most Americans Say They Don’t Trust Driverless Cars — Here’s Why
- Can The Critters in Your Mouth Cause or Cure Disease?
- KFF: A look at Part D enrollment trends for 2026
- Healthcare Dealmakers—Hims & Hers goes international with Eucalyptus purchase, Humana's CenterWell buys MaxHealth and more
- Some Patients Keep Weight off With Fewer GLP-1 Injections, Study Finds
- RFK Jr. Urges Medical Schools To Add More Nutrition Training
- Sixth Measles Case Confirmed in New Mexico Jail
- Community Health System selling 4 Arkansas hospitals to Freeman Health System for $112M
- Philips unveils Rembra CT for acute and high-demand imaging environments
- Philips unveils Rembra CT for acute and high-demand imaging environments
- 45,000 Halo Magic Sleepsuits For Babies Recalled Over Choking Risk
Generic left wing, health care, and pharmaceutical groups are coalescing into a political bloc which vows to derail the nomination of Robert F. Kennedy Jr. as the next Health & Human Services Secretary:
Kennedy opposed by advocates for US health post
By Michael Erman and Julie Steenhuysen - December 16, 2024Summary
* Coalition of 40+ groups opposes Kennedy's HHS nomination
* Groups are concerned about Kennedy's potential vaccine policies
* Advocates target Republican senators to block confirmationDec 16 (Reuters) - An expanding coalition of health and consumer advocates is campaigning against Robert F. Kennedy Jr.'s nomination to the top U.S. health job over concerns about his activism against vaccines and other health issues, according to the groups' representatives.
Obamacare advocate Protect Our Care, influential consumer group Public Citizen and Community Catalyst, which fights for equality in healthcare, are part of a coalition of at least 40 organizations targeting a group of Republican U.S. senators to help block Kennedy's confirmation as U.S. Secretary of Health and Human Services.
The Committee to Protect Health Care, a grassroots physician organization, has also amassed nearly 16,000 signatures from physicians who oppose Kennedy's nomination.
The efforts come as Kennedy heads to Capitol Hill to win support following his nomination by President-elect Donald Trump including by meeting with incoming Senate health committee chairman Republican Bill Cassidy, a Cassidy staff member confirmed.
"We’re going to work to block his nomination. And I think we will succeed," said Peter Maybarduk, access to medicines director of Public Citizen, a consumer group founded by Ralph Nader in 1971, which has worked for causes including drug safety and airbags in cars. "Even if RFK Jr. can't amass the power to take down vaccine funding, elevating his falsehoods to some kind of officialdom is a danger all its own."
Kennedy has long sown doubts about the safety and efficacy of vaccines that have helped curb disease and prevent deaths for decades. He disputes the anti-vaccine label and has said he would not prevent Americans from getting inoculations, but is a founder of the anti-vaccine group Children's Health Defense and in a 2023 interview with Lex Fridman said no vaccines are safe and effective.
Kennedy has said he wants to work to end chronic disease, break any ties between employees at the U.S. drugs regulator and industry, and advise U.S. water systems to remove fluoride. Trump has said he will discuss the U.S. childhood vaccination program with Kennedy, and on Monday said all vaccines should be looked at.
Kennedy's spokesperson did not respond to a request for comment. His advocates have said opposition to his nomination stems from corporate interests.
Protect Our Care Executive Director Brad Woodhouse said the group has hired lobbying and advocacy teams in more than six states to try to win over the Republican senators seen as possible "no" votes given their track records on health issues or because they are likely to face strong 2026 reelection challenges.
The groups are also raising money to buy ads and conduct polling on health issues, they said.
Protect Our Care, which works to defend the Affordable Care Act, said it will likely hold media briefings with public health experts and politicians to call attention to Kennedy's policies as he meets with senators.
Others have opposed the nomination as well. Pfizer board member Scott Gottlieb, a former FDA commissioner under Trump, told CNBC last month Kennedy's agenda "will cost lives in this country." The Wall Street Journal's Editorial Board in a Dec. 4 column wrote that Kennedy could "disrupt access to life-saving medicines and the innovation ecosystem that creates them."
HHS has oversight for the FDA, the Centers for Disease Control and Prevention and the National Institutes of Health.
TARGETING SENATORS
Confirmation of Kennedy and other cabinet nominees requires a majority vote in the Senate. Kennedy needs the backing of 50 out of the 53 Republican senators if all 47 Democrats vote against him. The advocates are targeting senators in states including Alaska, Idaho, North Carolina, Iowa, West Virginia and Maine.
American Values 2024, a Super PAC that supports Kennedy, has initiated a video campaign defending the nominee.
In a video it posted on social media platform X, Jay Carson, who used to work for President Bill Clinton and other Democrats but now supports Kennedy, argues that opposition to Kennedy stems from a smear campaign by pharmaceutical companies.
"They're determined to keep him out of Washington, D.C.," the Super PAC said on X.
The top lobby group for drugmakers, Pharmaceutical Research and Manufacturers of America, declined to comment. In a Nov. 14 statement, the industry said it wants to work with the Trump administration.
Community Catalyst, which has raised millions since 1998 to support equal access to healthcare, said Kennedy's anti-vaccine rhetoric and position against fluoridated water pushed it to act.
Mona Shah, Community Catalyst's senior director of policy and strategy, said the group has worked for decades to improve dental care access in hard-to-reach communities that face racial discrimination where removing fluoride from drinking water could do the greatest harm.
"We really feel that some of these policies would hurt communities, really endanger children and families and truly make us sicker as a nation," Shah said.
The Committee to Protect Health Care's petition describes Kennedy's appointment as a threat to patient safety and "an affront" to public health. The group accepts no pharmaceutical industry funding.
Dr. Rob Davidson, the group's executive director and an emergency room physician in Michigan, said Americans need to be aware of Kennedy's "very dangerous" positions on topics like vaccines, and COVID-19 being engineered to target certain racial populations.
"We want to make sure people understand he's not just a kooky guy who says weird things," Davidson said.
More:
https://www.politico.com/live-updates/2024/12/16/congress/rfk-jr-opponents-buy-ads-00194493
RFK Jr. opponents buy ads in key senators’ states
By Daniel Payne - December 16, 2024Opponents of Robert F. Kennedy Jr.’s nomination to lead HHS are buying tens of thousands of dollars in ads across the states of key Republican senators as he plans to meet with them this week.
Protect Our Care, which has launched a Stop RFK War Room, has bought advertising slots — from digital ads to billboards — calling on constituents to urge their senators to oppose Kennedy’s nomination, leaders of the group told POLITICO.
“We’re going to accelerate our activity,” said Brad Woodhouse, executive director of Protect Our Care, a health advocacy group aligned with Democrats. “We think this week’s a big deal.”
The group is targeting GOP senators it believes could be persuaded to vote against Kennedy’s confirmation: Sens. Lisa Murkowski (R-Alaska), Mike Crapo (R-Idaho), Susan Collins (R-Maine), Bill Cassidy (R-La.), Thom Tillis (R-N.C.), Mike Rounds (R-S.D.), John Cornyn (R-Texas), Shelley Moore Capito (R-W.Va.) and the newly elected Jim Justice (R-W.Va.).
The ads connect Kennedy’s unsupported claims about the danger of vaccines to the deaths of more than 80 children during a measles outbreak in Samoa in 2019 — and argue that health professionals, scientists and the conservative Wall Street Journal editorial board oppose his confirmation, making it a safe position for Republicans.
Why it matters: Protect Our Care, along with several groups focused on public health, are arguing to senators — and the public — that Kennedy’s views on vaccines, medical authorities and key health policies would be detrimental to the U.S. population, should he lead HHS.
To block Kennedy, four Republican senators would have to oppose his confirmation if every Democrat votes no.
What’s next? Protect Our Care expects more campaigning against the nominee in the future.
“We will spend more,” Woodhouse said. “We’re just starting this process.”
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.













